journal article·2024-11Open access

Engineering a Microfluidic Platform to Cryopreserve Stem Cells: A DMSO‐Free Sustainable Approach

Saman Modaresi, Settimio Pacelli, Aishik Chakraborty, Ali Coyle, Wei Luo, Irtisha Singh, Arghya Paul

Advanced Healthcare Materials· Volume 13· Issue 29

Abstract

Abstract Human adipose‐derived stem cells (hASCs) are cryopreserved traditionally using dimethyl sulfoxide (DMSO) as the cryoprotectant agent. DMSO penetrates cell membranes and prevents cellular damage during cryopreservation. However, DMSO is not inert to cells, inducing cytotoxic effects by causing mitochondrial dysfunction, reduced cell proliferation, and impaired hASCs transplantation. Additionally, large‐scale production of DMSO and contamination can adversely impact the environment. A sustainable, green alternative to DMSO is trehalose, a natural disaccharide cryoprotectant agent that does not pose any risk of cytotoxicity. However, the cellular permeability of trehalose is less compared to DMSO. Here, a microfluidic chip is developed for the intracellular delivery of trehalose in hASCs. The chip is designed for mechanoporation, which creates transient pores in cell membranes by mechanical deformation. Mechanoporation allows the sparingly permeable trehalose to be internalized within the cell cytosol. The amount of trehalose delivered intracellularly is quantified and optimized based on cellular compatibility and functionality. Furthermore, whole‐transcriptome sequencing confirms that less than 1% of all target genes display at least a twofold change in expression when cells are passed through the chip compared to untreated cells. Overall, the results confirm the feasibility and effectiveness of using this microfluidic chip for DMSO‐free cryopreservation of hASCs.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Tissue Engineering and Regenerative Medicine · Pluripotent Stem Cells Research · 3D Printing in Biomedical Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemical and Petroleum Engineering Bioengineering Graduate Program School of Engineering The University of Kansas Lawrence KS 66045 USA

Department of Biomedical Engineering Illinois Institute of Technology Chicago IL 60616 USA

Department of Chemical and Biochemical Engineering The University of Western Ontario London ON N6A 5B9 Canada

Collaborative Specialization in Musculoskeletal Health Research and Bone and Joint Institute The University of Western Ontario London ON N6A 5B9 Canada

School of Biomedical Engineering The University of Western Ontario London ON N6A 5B9 Canada

Department of Cell Biology and Genetics College of Medicine Texas A&M University Bryan TX 77807 USA

Department of Biomedical Engineering College of Engineering Texas A&M University College Station TX 77843 USA

Interdisciplinary Program in Genetics and Genomics Texas A&M University College Station TX 77840 USA

Department of Chemistry The Center for Advanced Materials and Biomaterials Research The University of Western Ontario London ON N6A 5B9 Canada

Funding

Canadian Institutes of Health Research

References (82)

Show source-provided references
1. 10.1159/00032662310.1159/000326623 ↗
2. 10.1186/s13287-016-0461-610.1186/s13287-016-0461-6 ↗
3. 10.18502/rmm.v5i4.306010.18502/rmm.v5i4.3060 ↗
4. 10.1155/2016/694028310.1155/2016/6940283 ↗
5. 10.5978/islsm.13-RE-0110.5978/islsm.13-RE-01 ↗
6. 10.4055/cios.2018.10.3.27110.4055/cios.2018.10.3.271 ↗
7. 10.4161/org.5.3.958510.4161/org.5.3.9585 ↗
8. 10.1155/2012/65203410.1155/2012/652034 ↗
9. 10.1016/j.actbio.2017.12.02510.1016/j.actbio.2017.12.025 ↗
10. 10.1016/j.jcyt.2012.12.00910.1016/j.jcyt.2012.12.009 ↗
11. 10.1177/153537021350680210.1177/1535370213506802 ↗
12. 10.3324/haematol.2014.10471110.3324/haematol.2014.104711 ↗
13. 10.1158/0008-5472.CAN-07-527210.1158/0008-5472.CAN-07-5272 ↗
14. 10.1002/adbi.20230015510.1002/adbi.202300155 ↗
15. 10.1021/acsnano.1c1022110.1021/acsnano.1c10221 ↗
16. 10.1038/ncomms424410.1038/ncomms4244 ↗
17. 10.1021/acsami.8b1623610.1021/acsami.8b16236 ↗
18. 10.1016/j.imr.2016.12.00110.1016/j.imr.2016.12.001 ↗
19. 10.1016/j.cryobiol.2014.04.00710.1016/j.cryobiol.2014.04.007 ↗
20. 10.1038/7260810.1038/72608 ↗
21. 10.1016/j.bbamem.2016.03.02010.1016/j.bbamem.2016.03.020 ↗
22. 10.1002/adbi.20220028510.1002/adbi.202200285 ↗
23. 10.1016/j.bios.2006.12.02310.1016/j.bios.2006.12.023 ↗
24. 10.1016/j.scr.2018.07.02110.1016/j.scr.2018.07.021 ↗
25. 10.1016/j.cryobiol.2024.10484710.1016/j.cryobiol.2024.104847 ↗
26. 10.1021/acsami.5b0065510.1021/acsami.5b00655 ↗
27. 10.1096/fj.13-23544010.1096/fj.13-235440 ↗
28. 10.2217/rme-2019-014510.2217/rme-2019-0145 ↗
29. 10.1038/s41598-019-40660-010.1038/s41598-019-40660-0 ↗
30. 10.1038/nmeth.244210.1038/nmeth.2442 ↗
31. 10.1002/ajh.2070710.1002/ajh.20707 ↗
32. 10.1289/ehp.617110.1289/ehp.6171 ↗
33. 10.1016/S0038-0717(02)00288-210.1016/S0038-0717(02)00288-2 ↗
34. 10.1371/journal.pone.002760410.1371/journal.pone.0027604 ↗
35. 10.3390/molecules2211178910.3390/molecules22111789 ↗
36. 10.1089/rej.2014.165610.1089/rej.2014.1656 ↗
37. 10.1186/s40824-023-00356-z10.1186/s40824-023-00356-z ↗
38. 10.1021/acs.molpharmaceut.3c0079810.1021/acs.molpharmaceut.3c00798 ↗
39. 10.1177/15347346231155751/ASSET/IMAGES/LARGE/10.1177_15347346231155751‐FIG8.JPEG10.1177/15347346231155751/ASSET/IMAGES/LARGE/10.1177_15347346231155751‐FIG8.JPEG ↗
40. 10.1038/s41598-016-0028-x10.1038/s41598-016-0028-x ↗
41. 10.1021/acs.langmuir.8b0201510.1021/acs.langmuir.8b02015 ↗
42. 10.1088/0957-4484/20/27/27510110.1088/0957-4484/20/27/275101 ↗
43. 10.1089/15383440432270874510.1089/153834404322708745 ↗
44. 10.1371/journal.pone.013032310.1371/journal.pone.0130323 ↗
45. 10.1016/S1095-6433(01)00505-010.1016/S1095-6433(01)00505-0 ↗
46. 10.1039/D0LC01224F10.1039/D0LC01224F ↗
47. 10.1016/j.mtbio.2021.10019310.1016/j.mtbio.2021.100193 ↗
48. 10.1002/advs.20200459510.1002/advs.202004595 ↗
49. 10.1021/nl303421h10.1021/nl303421h ↗
50. 10.1073/pnas.180967111510.1073/pnas.1809671115 ↗
51. 10.1016/j.mattod.2018.03.00210.1016/j.mattod.2018.03.002 ↗
52. 10.1073/pnas.121870511010.1073/pnas.1218705110 ↗
53. 10.1371/journal.pone.011880310.1371/journal.pone.0118803 ↗
54. 10.1038/srep1027610.1038/srep10276 ↗
55. 10.1088/1361-6528/ac8d9910.1088/1361-6528/ac8d99 ↗
56. 10.1002/adtp.20190013010.1002/adtp.201900130 ↗
57. 10.1021/acsomega.7b0115810.1021/acsomega.7b01158 ↗
58. 10.1021/acs.molpharmaceut.9b0063910.1021/acs.molpharmaceut.9b00639 ↗
59. 10.1021/acsami.8b0520010.1021/acsami.8b05200 ↗
60. 10.1126/sciadv.abl940410.1126/sciadv.abl9404 ↗
61. 10.1093/bioinformatics/bts63510.1093/bioinformatics/bts635 ↗
62. 10.1186/s13059-014-0550-810.1186/s13059-014-0550-8 ↗
63. 10.1002/wrna.136410.1002/wrna.1364 ↗
64. Chen S. · ACS Appl. Mater. Interfaces · 2020 · 12
65. 10.3390/cells1007183710.3390/cells10071837 ↗
66. 10.1007/s00232-016-9916-z10.1007/s00232-016-9916-z ↗
67. 10.1021/ac300264v10.1021/ac300264v ↗
68. 10.1038/3504665910.1038/35046659 ↗
69. 10.1371/journal.pone.027059910.1371/journal.pone.0270599 ↗
70. 10.1186/s12964-019-0438-z10.1186/s12964-019-0438-z ↗
71. 10.1126/science.281.5381.132210.1126/science.281.5381.1322 ↗
72. 10.1073/pnas.20120879810.1073/pnas.201208798 ↗
73. 10.1038/onc.2009.4410.1038/onc.2009.44 ↗
74. 10.3727/096368912X66244410.3727/096368912X662444 ↗
75. 10.1089/ten.tea.2007.042910.1089/ten.tea.2007.0429 ↗
76. 10.1161/01.CIR.0000121425.42966.F110.1161/01.CIR.0000121425.42966.F1 ↗
77. Trzyna A. · Biomolecules 2021 · 2004 · 11 · 878
78. 10.1016/j.biomaterials.2015.01.02210.1016/j.biomaterials.2015.01.022 ↗
79. 10.1007/s10856-017-6004-610.1007/s10856-017-6004-6 ↗
80. 10.1038/s41598-017-17765-510.1038/s41598-017-17765-5 ↗
81. 10.3390/ijms1701012410.3390/ijms17010124 ↗
82. 10.1016/j.aquaculture.2017.12.04510.1016/j.aquaculture.2017.12.045 ↗